Dostarlimab and Cobolimab in Advanced Cervical Cancer

NCT06238635 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Advanced Cervical Carcinoma
Metastatic Cervical Cancer
Metastatic Cervical Carcinoma
Recurrent Cervical Carcinoma

Interventions

DRUG: Dostarlimab
DRUG: Cobolimab

Sponsor

Meghan Shea

Collaborators

[object Object]